Velocity Clinical Research, Lafayette

Lafayette, Louisiana 70809

6 studies enrolling now · 18 studies all time

What they study most

COVID-19, Chronic Spontaneous Urticaria, Cortisol Excess, Diabetic Peripheral Neuropathic Pain, Endometrial Hyperplasia, Gastroenteritis, Healthy Volunteers, Influenza, Peanut Allergy, Pneumococcal Disease, RSV Infection, Recurrent Wheezing

Studies at this site

• A Study of BLB-201 RSV Vaccine in Infants and Children — Recruiting now
• Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy — Recruiting now
• Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents — Recruiting now
• A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose — Recruiting now
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Recruiting now
• A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts — Recruiting now
• Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months — Withdrawn before enrolling
• A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults — Completed
• Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) — Completed
• Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection — Stopped early
• Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy — Completed
• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing — Running, not enrolling
• A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age — Completed
• A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age — Completed
• A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age — Completed
• A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus — Completed
• Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines — Completed